Dr. Michael V Chiorean
Claim this profileVirginia Mason Medical Center
Studies Crohn's Disease
1 reported clinical trial
1 drug studied
Affiliated Hospitals
Clinical Trials Michael V Chiorean is currently running
More about Michael V Chiorean
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Michael V Chiorean has experience with
- Mirikizumab
Breakdown of trials Michael V Chiorean has run
Crohn's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael V Chiorean specialize in?
Michael V Chiorean focuses on Crohn's Disease and other conditions. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Michael V Chiorean currently recruiting for clinical trials?
Yes, Michael V Chiorean is currently recruiting for 1 clinical trial in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Michael V Chiorean has studied deeply?
Yes, Michael V Chiorean has studied treatments such as Mirikizumab.
What is the best way to schedule an appointment with Michael V Chiorean?
Apply for one of the trials that Michael V Chiorean is conducting.
What is the office address of Michael V Chiorean?
The office of Michael V Chiorean is located at: Virginia Mason Medical Center, Seattle, Washington 98111 United States. This is the address for their practice at the Virginia Mason Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.